CD79B and B-cell chronic lymphocytic leukemia: Further, ZAP-70 expression can enhance BCR signaling after anti-IgM treatment, independent of its kinase activity[44], and CLL cells that expressed ZAP-70 had significantly higher levels of phosphorylated CD79b compared to CLL lacking ZAP-70.